Definitive Healthcare Corp. (DH) intrinsic value & 10-year financials
Definitive Healthcare Corp. (DH) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 8 fiscal years revenue grew 19.2% a year to $241.5M, with an average return on invested capital of -21.0%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $1.00
- Market cap
- $106.7M
- Revenue (FY2025)
- $241.5M
- Revenue growth (8-yr CAGR)
- 19.2%
- ROIC (10-yr avg)
- -21.0%
- Free cash flow (FY2025)
- $37.1M
DH 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $241.5M | -$138.9M | -$1.30 | $37.1M | -92.9% | -38.0% |
| FY2024 | $252.2M | -$413.1M | -$3.54 | $45.9M | -281.8% | -63.2% |
| FY2023 | $251.4M | -$202.4M | -$1.79 | $38.2M | -131.2% | -20.8% |
| FY2022 | $222.7M | -$6.0M | -$0.06 | $27.3M | -18.5% | -1.4% |
| FY2021 | $166.2M | -$17.7M | -$0.19 | $18.5M | -15.0% | -1.7% |
| FY2020 | $118.3M | -$51.2M | — | $21.8M | -12.2% | -0.9% |
| FY2019 | $84.1M | — | — | — | — | — |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Definitive Healthcare Corp. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Definitive Healthcare Corp. has historically struggled to out-earn its cost of capital, averaging just -21.0% ROIC.
Definitive Healthcare Corp. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, Definitive Healthcare Corp. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-43.18 per share.